The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Infinity to Present at the 25th Annual Roth Conference

Monday, March 11, 2013

Infinity to Present at the 25th Annual Roth Conference08:00 EDT Monday, March 11, 2013 CAMBRIDGE, Mass. (Business Wire) -- Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) will be presenting at the 25th Annual ROTH Conference on March 18, 2013, at 3:00 p.m. PT (6:00 p.m. ET) in Laguna Nigel, CA. A live webcast of Infinity's presentation will be accessible on the “investors/media” section of the company's website, www.infi.com, and will be available for 30 days following the event. About Infinity Pharmaceuticals, Inc. Infinity is an innovative drug discovery and development company seeking to discover, develop and deliver to patients best-in-class medicines for diseases with significant unmet need. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs focused on the inhibition of phosphoinositide-3-kinase and heat shock protein 90 are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at www.infi.com. Infinity Pharmaceuticals, Inc.Kate Murray, 617-453-1179Kate.Murray@infi.comhttp://www.infi.com